These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1110607)

  • 61. Dopamine accumulation after dopamine beta-hydroxylase inhibition in rat heart as an index of norepinephrine turnover.
    Fuller RW; Snoddy HD; Perry KW
    Life Sci; 1982 Aug; 31(6):563-70. PubMed ID: 6290819
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Secretion of proteins (chromogranin A and dopamine -hydroxylase) from a sympathetic neuron.
    Smith AD
    Philos Trans R Soc Lond B Biol Sci; 1971 Jun; 261(839):363-70. PubMed ID: 4108422
    [No Abstract]   [Full Text] [Related]  

  • 63. Differentiation of norepinephrine storage compartments in peripheral adrenergic nerves.
    Van Orden LS; Schaefer JM; Burke JP; Lodoen FV
    J Pharmacol Exp Ther; 1970 Sep; 174(3):357-68. PubMed ID: 5456169
    [No Abstract]   [Full Text] [Related]  

  • 64. Inhibition by cyclopropane of release od norepinephrine, but not dopamine-beta-hydroxylase, from the guinea-pig vas deferens.
    Roizen MF; Thoa NB; Moss J; Kopin IJ
    Anesthesiology; 1976 Jan; 44(1):54-6. PubMed ID: 1244775
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dopamine- -hydroxylase in the rat brain: developmental characteristics.
    Coyle JT; Axelrod J
    J Neurochem; 1972 Feb; 19(2):449-59. PubMed ID: 4621978
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of 2-mercaptoethylguanidine and other compounds on norepinephrine synthesis by adrenal medullary granules.
    Diliberto EJ; DiStefano V
    Biochem Pharmacol; 1973 Dec; 22(23):2947-60. PubMed ID: 4761560
    [No Abstract]   [Full Text] [Related]  

  • 67. Enhanced release of dopamine -hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3', 5'-monophosphate and theophylline.
    Wooten GF; Thoa NB; Kopin IJ; Axelrod J
    Mol Pharmacol; 1973 Mar; 9(2):178-83. PubMed ID: 4351235
    [No Abstract]   [Full Text] [Related]  

  • 68. Accumulation and loss of noradrenaline central to a constriction on adrenergic nerves.
    Boyle FC; Gillespie JS
    Eur J Pharmacol; 1970 Sep; 12(1):77-84. PubMed ID: 5472268
    [No Abstract]   [Full Text] [Related]  

  • 69. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of tyramine and guanethidine on dopamine-beta-hydroxylase activity and norepinephrine concentrations in vesicular fraction of the heart and plasma of rats.
    Grobecker H; Roizen MF; Kopin IJ
    Life Sci; 1977 Mar; 20(6):1009-15. PubMed ID: 850457
    [No Abstract]   [Full Text] [Related]  

  • 71. [The feasibility of studying adrenergic innervation at different periods following death].
    Shustova TI
    Arkh Anat Gistol Embriol; 1974 Dec; 67(12):88-90. PubMed ID: 4451474
    [No Abstract]   [Full Text] [Related]  

  • 72. Release of noradrenaline and dopamine by nerve stimulation in the cat spleen perfused with 3 H-dopamine.
    Kirpekar SM; Yamamoto H
    Br J Pharmacol; 1971 Sep; 43(1):86-96. PubMed ID: 5136467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 74. Noradrenaline storage particles in splenic nerve.
    De Potter WP
    Philos Trans R Soc Lond B Biol Sci; 1971 Jun; 261(839):313-7. PubMed ID: 4399625
    [No Abstract]   [Full Text] [Related]  

  • 75. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 76. Changes of norepinephrine levels, tyrosine hydroxylase and dopamine-beta-hydroxylase activities after castration and testosterone treatment in vas deferens of adult rats.
    Bustamante D; Lara H; Belmar J
    Biol Reprod; 1989 Mar; 40(3):541-8. PubMed ID: 2569330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of nerve stimulation on the axonal transport of noradrenaline and dopamine-beta-hydroxylase.
    Keen P; McLean WG
    Br J Pharmacol; 1974 Dec; 52(4):527-31. PubMed ID: 4141914
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Release of dopamine-beta-hydroxylase with norepinephrine during cat splenic nerve stimulation.
    Gewirtz GP; Kopin IJ
    Nature; 1970 Jul; 227(5256):406-7. PubMed ID: 4913714
    [No Abstract]   [Full Text] [Related]  

  • 79. The role of norepinephrine in the function of the area postrema. I. Immunofluorescent localization of dopamine-beta-hydroxylase and electron microscopy.
    Torack RM; Stranahan P; Hartman BK
    Brain Res; 1973 Oct; 61():235-52. PubMed ID: 4589691
    [No Abstract]   [Full Text] [Related]  

  • 80. Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes.
    Bencsics A; Sershen H; Baranyi M; Hashim A; Lajtha A; Vizi ES
    Brain Res; 1997 Jul; 761(2):236-43. PubMed ID: 9252021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.